Redsense Medical AB (publ) (RDSNF)
OTCMKTS · Delayed Price · Currency is USD
0.5100
-0.5400 (-51.43%)
At close: Aug 2, 2024
Redsense Medical AB Revenue
Redsense Medical AB had revenue of 4.88M SEK in the quarter ending March 31, 2025, with 181.65% growth. This brings the company's revenue in the last twelve months to 31.92M, up 57.58% year-over-year. In the year 2024, Redsense Medical AB had annual revenue of 28.77M with 12.74% growth.
Revenue (ttm)
31.92M SEK
Revenue Growth
+57.58%
P/S Ratio
3.20
Revenue / Employee
6.38M SEK
Employees
5
Market Cap
10.16M USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28.77M | 3.25M | 12.74% |
Dec 31, 2023 | 25.52M | 8.76M | 52.32% |
Dec 31, 2022 | 16.75M | 410.00K | 2.51% |
Dec 31, 2021 | 16.34M | -757.98K | -4.43% |
Dec 31, 2020 | 17.10M | 2.87M | 20.19% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |